Collplant Biotechnologies LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
George Walter Loewenbaum and affiliated entities have filed an amended Schedule 13G/A, disclosing a combined passive beneficial ownership in CollPlant Biotechnologies Ltd., with George Walter Loewenbaum holding 9.96% of the ordinary shares.